Cigna Group’s Express Scripts reached a settlement with federal antitrust enforcers to resolve allegations that the company artificially inflated the price of insulin for patients through illegal rebate tactics.
Cigna Settles FTC Lawsuit Alleging It Inflated Insulin Costs
